Effect of lithium on hypothalamic‐pituitary dopaminergic function
- 1 January 1978
- journal article
- research article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 57 (1) , 91-96
- https://doi.org/10.1111/j.1600-0447.1978.tb06876.x
Abstract
The effect of lithium on apomorphine-induced growth hormone secretion and haloperidol-induced prolactin secretion was examined in eight male subjects without history of manic-depressive illness. Lithium had no effect on baseline or drug-induced changes in serum growth hormone or prolactin concentrations. These data suggest that lithium does not alter hypothalamic-pituitary dopamine receptor function.Keywords
This publication has 23 references indexed in Scilit:
- Lithium inhibition of cyclic AMP accumulation induced by dopamine in isolated retinae of the rabbitBiochemical Pharmacology, 1977
- Lithium levels in monkey and human brain after chronic, therapeutic, oral dosagePharmacology Biochemistry and Behavior, 1976
- Lithium in Tardive Dyskinesia*Pharmacopsychiatry, 1976
- Effect of Lithium on Neuroleptic-induced Tardive Dyskinesia Compared with Placebo in a Double-Blind Cross-over TrialPharmacopsychiatry, 1975
- Potentiation by lithium of the haloperidol-induced behavioural suppressionJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1974
- TREATMENT OF HUNTINGTON'S CHOREA WITH LITHIUM CARBONATE A Double-blind TrialThe Lancet, 1974
- LITHIUM AND LEVODOPA IN PARKINSONISMThe Lancet, 1973
- LITHIUM THERAPY IN HUNTINGTON'S CHOREA AND TARDIVE DYSKINESIAThe Lancet, 1973
- EFFECT OF APOMORPHINE ON HUMAN-GROWTH-HORMONE SECRETIONThe Lancet, 1972
- PROPHYLACTIC LITHIUM: DOUBLE BLIND DISCONTINUATION IN MANIC-DEPRESSIVE AND RECURRENT-DEPRESSIVE DISORDERSThe Lancet, 1970